Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant

por Meermeier, Erin W., Bergsagel, P. Leif
Publicado 2023

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression

por Hussain, Sajjad, Bedekovics, Tibor, Chesi, Marta, Bergsagel, P. Leif, Galardy, Paul J.
Publicado 2015

Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups

por Asmann, Yan W., Parikh, Kaushal, Bergsagel, P. Leif, Dong, Haidong, Adjei, Alex A., Borad, Mitesh J., Mansfield, Aaron S.
Publicado 2021

Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myeloma

por Vardam-Kaur, Trupti, Pathangey, Latha B., McCormick, Daniel J., Bergsagel, P. Leif, Cohen, Peter A., Gendler, Sandra J.
Publicado 2021

Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells

por Suzuki, Erika, Demo, Susan, Deu, Edgar, Keats, Jonathan, Arastu-Kapur, Shirin, Bergsagel, P. Leif, Bennett, Mark K., Kirk, Christopher J.
Publicado 2011

MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites

por Pei, Huadong, Zhang, Lindsey, Luo, Kuntian, Qin, Yuxin, Chesi, Marta, Fei, Frances, Bergsagel, P. Leif, Wang, Liewei, You, Zhongsheng, Lou, Zhenkun
Publicado 2011

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma

por Jain, Tania, Narayanasamy, Hemalatha, Mikhael, Joseph, Reeder, Craig B., Bergsagel, P. Leif, Mayo, Angela, Stewart, A. Keith, Mookadam, Farouk, Fonseca, Rafael
Publicado 2017

Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma

por Affer, Maurizio, Chesi, Marta, Chen, Wei-Dong G., Keats, Jonathan J., Demchenko, Yulia N., Roschke, Anna V., Van Wier, Scott, Fonseca, Rafael, Bergsagel, P. Leif, Kuehl, W. Michael
Publicado 2014

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

por Calcinotto, Arianna, Ponzoni, Maurilio, Ria, Roberto, Grioni, Matteo, Cattaneo, Elena, Villa, Isabella, Sabrina Bertilaccio, Maria Teresa, Chesi, Marta, Rubinacci, Alessandro, Tonon, Giovanni, Bergsagel, P Leif, Vacca, Angelo, Bellone, Matteo
Publicado 2015

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms

por Gagnon, Marie-France, Tian, Shulan, Geyer, Susan, Sharma, Neeraj, Vachon, Celine M., Kusne, Yael, Bergsagel, P. Leif, Stewart, A. Keith, Rajkumar, S. Vincent, Kumar, Shaji, Ailawadhi, Sikander, Baughn, Linda B.
Publicado 2022

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

por Zhu, Yuan Xiao, Shi, Chang-Xin, Bruins, Laura A., Wang, Xuewei, Riggs, Daniel L., Porter, Brooke, Ahmann, Jonathan M., de Campos, Cecilia Bonolo, Braggio, Esteban, Bergsagel, P. Leif, Stewart, A. Keith
Publicado 2019

Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression

por Croucher, Danielle C., Richards, Laura M., Tsofack, Serges P., Waller, Daniel, Li, Zhihua, Wei, Ellen Nong, Huang, Xian Fang, Chesi, Marta, Bergsagel, P. Leif, Sebag, Michael, Pugh, Trevor J., Trudel, Suzanne
Publicado 2021

Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients

por Rajkumar, S, Abdallah, Nadine, Lakshman, Arjun, Kumar, Shaji, Cook, Joselle, Binder, Moritz, Kapoor, Prashant, Dispenzieri, Angela, Gertz, Morie, Lacy, Martha, HAYMAN, Suzanne, Buadi, Francis, Dingli, David, Lin, Yi, Kourelis, Taxiarchis, Warsame, Rahma, Bergsagel, P. Leif
Publicado 2023

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma

por Villa, Nancy Y., Rahman, Masmudur M., Mamola, Joseph, Sharik, Meaghen E., de Matos, Ana Lemos, Kilbourne, Jacquelyn, Lowe, Kenneth, Daggett-Vondras, Juliane, D'Isabella, Julia, Goras, Elizabeth, Chesi, Marta, Bergsagel, P. Leif, McFadden, Grant
Publicado 2022

Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma

por Bansal, Radhika, Baksh, Mizba, Larsen, Jeremy T., Hathcock, Matthew A., Dingli, David, Stewart, A. Keith, Kapoor, Prashant, Kourelis, Taxiarchis, Hayman, Suzanne R., Warsame, Rahma M., Fonseca, Rafael, Bergsagel, P. Leif, Ailawadhi, Sikander, Kumar, Shaji K., Lin, Yi
Publicado 2023

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

por Baughn, Linda B., Li, Zhuo, Pearce, Kathryn, Vachon, Celine M., Polley, Mei-Yin, Keats, Jonathan, Elhaik, Eran, Baird, Michael, Therneau, Terry, Cerhan, James R., Bergsagel, P. Leif, Dispenzieri, Angela, Rajkumar, S. Vincent, Asmann, Yan W., Kumar, Shaji
Publicado 2020

The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma

por Sharma, Neeraj, Smadbeck, James B., Abdallah, Nadine, Zepeda-Mendoza, Cinthya, Binder, Moritz, Pearce, Kathryn E., Asmann, Yan W., Peterson, Jess F., Ketterling, Rhett P., Greipp, Patricia T., Bergsagel, P. Leif, Rajkumar, S. Vincent, Kumar, Shaji K., Baughn, Linda B.
Publicado 2021

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

por Fonseca, Rodrigo, Arribas, Mariano, Wiedmeier-Nutor, Julia E., Kusne, Yael N., González Vélez, Miguel, Kosiorek, Heidi E., Butterfield, Richard (Duke) J., Kirsch, Ilan R., Mikhael, Joseph R., Stewart, A. Keith, Reeder, Craig, Larsen, Jeremy, Bergsagel, P. Leif, Fonseca, Rafael
Publicado 2023

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

por Fonseca, Rodrigo, Arribas, Mariano, Wiedmeier-Nutor, Julia E., Kusne, Yael N., González Vélez, Miguel, Kosiorek, Heidi E., Butterfield, Richard (Duke) J., Kirsch, Ilan R., Mikhael, Joseph R., Stewart, A. Keith, Reeder, Craig, Larsen, Jeremy, Bergsagel, P. Leif, Fonseca, Rafael
Publicado 2023

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

por Stein, Caleb K., Pawlyn, Charlotte, Chavan, Shweta, Rasche, Leo, Weinhold, Niels, Corken, Adam, Buros, Amy, Sonneveld, Pieter, Jackson, Graham H., Landgren, Ola, Mughal, Tariq, He, Jie, Barlogie, Bart, Bergsagel, P. Leif, Davies, Faith E., Walker, Brian A., Morgan, Gareth J.
Publicado 2017